|
|
|
Volumn 22, Issue 3, 2009, Pages 418-439
|
|
Cell therapy for Parkinson's disease: IV. Risks and future trends
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADULT;
ALLOTRANSPLANTATION;
ANIMAL;
BABOON;
CLINICAL PROTOCOL;
COMPARATIVE STUDY;
CYTOLOGY;
DISEASE MODEL;
EMBRYONIC STEM CELL;
ETHICS;
EUROPE;
FORECASTING;
HAPLORHINI;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MESENCHYMAL STEM CELL;
PARKINSON DISEASE;
REVIEW;
RISK FACTOR;
SAFETY;
STEM CELL;
STEM CELL TRANSPLANTATION;
SWINE;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
XENOGRAFT;
ZOONOSIS;
ADULT;
ANIMALS;
CLINICAL PROTOCOLS;
DISEASE MODELS, ANIMAL;
EMBRYONIC STEM CELLS;
ETHICS;
EUROPE;
FORECASTING;
HAPLORHINI;
HUMANS;
IMMUNOTHERAPY;
MESENCHYMAL STEM CELLS;
PAPIO;
PARKINSON DISEASE;
RISK FACTORS;
SAFETY;
STEM CELL TRANSPLANTATION;
STEM CELLS;
SWINE;
TRANSPLANTATION, HETEROLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
ZOONOSES;
|
|
EID: 77954634719
PISSN: 15619125
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (163)
|
